Information provided by Ecsponent Biotech, (www.ecsbio.com) on behalf of:
This is for information and educational purposes only, and should not be construed
as healthcare advice. Please discuss with your healthcare professional. A full list of
references is available on the website and at our offices. Data on file.
DOC 9.0.1.105.9.SA V1 Effective date: 5 May 2017
Reference:
National Cord Blood Program, http://www.nationalcordbloodprogram.org/patients/ncbp_diseases.pdf
https://parentsguidecordblood.org/en/diseases#standard
Diseases Currently Treatable
(Most Common)
BLOOD CANCERS
Acute Lymphoblastic Leukaemia (ALL)
Acute Myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Myelodysplastic Syndrome (MDS)
Multiple Myeloma
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Bone marrow failure syndromes
Severe Aplastic Anaemia, Unspecified
Fanconi Anaemia
BLOOD DISORDERS
Sickle Cell Disease
Thalassemia
IMMUNODEFICIENCIES
Severe Combined Immune
Deficiency (SCID)
Wiskott-Aldrich Syndrome
INHERITED METABOLIC
DISORDERS
Hurler Disease (MPS type IH)
Osteopetrosis
Adrenoleukodystrophy
Krabbe Disease
AUTOIMMUNE DISEASES
Systemic Lupus (SLE)
NEUROLOGIC DISORDER
Autism (Phase 2)
Cerebral Palsy (Phase 2)
Hearing Loss (acquired sensori-neural)
(Phase 2)
Hypoxic Ischemic Encephalopathy (HIE)
(Phase 1)
Spinal Cord Injury (Phase 2)
AUTO-IMMUNE DISORDERS
Crohn's Disease (Phase 3)
Diabetes, Type 1 (Phase 2)
Graft-versus-Host Disease (GvHD)
(Phase 3)
Kidney plus stem cell transplant
(Phase 2)
Systemic Lupus (SLE) (Phase 2)
Multiple Sclerosis (Phase 1)
Rheumatoid Arthritis (Phase 2)
Scleroderma (Phase 2)
CARDIOVASCULAR
Critical Limb Ischemia
(Phase 3)
Ischemic Stroke
(Phase 2 placenta) (Phase 3)
Myocardial Infarction (Phase 3)
Cardiomyopathy (Phase 3)
Therapies in Clinical Trials
with cord blood
